TrialInternational journal of hematology2022

Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.

Yoko Edahiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.